1-2 of 2
Christine Lefebvre, MD PhD
Close
Sort by
Journal Articles

Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities. on Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group

Elise Chapiro, MD PhD, Damien Roos-Weil, MD, Nadia Bougacha, Clementine Gabillaud, Clémentine Dillard, Elodie Pramil, Melanie Yon, Karim Maloum, MD PhD, Catherine Settegrana, Lucile Baseggio, MD, Claude Lesty, Frederic Davi, MD PhD, Magali Le Garff-Tavernier, M'boyba Khadija Diop, Nathalie M Droin, PhD, Philippe Dessen, Veronique Leblond, Caroline Algrin, Simon Bouzy, Virginie Eclache, Baptiste Gaillard, Evelyne Callet-Bauchu, Marc Muller, MD, Christine Lefebvre, MD PhD, Nathalie Nadal, Antoine Ittel, PharmD, Stéphanie Struski, Marie-Agnes Collonge-Rame, Benoit Quilichini, Sandra Fert-Ferrer, Nathalie Auger, Isabelle Radford-Weiss, Lena Wagner, Sebastian Scheinost, Thorsten Zenz, MD, Santos Susin, Olivier Bernard, Florence Nguyen-Khac, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 943.
https://doi.org/10.1182/blood-2018-99-115085
Published: 2018
Journal Articles

Mechanisms of Improvement of Erythropoiesis with Low Dose Deferasirox in Low Risk Myelodysplastic Syndromes

Mathieu Meunier, Sarah Ancelet, Christine Lefebvre, MD PhD, Josiane Arnaud, Catherine Garrel, Yan Wang, Patrice Faure, Benoit Polack, MD PhD, Jean-Yves Cahn, MD, Sophie Park, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3152.
https://doi.org/10.1182/blood.V128.22.3152.3152
Published: 2016